CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome

Clinical trial NCT05617625 · SUSPENDED

Trial details

NCT number: NCT05617625
Sponsor: Guenther Koehne
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Graft Vs Host Disease Graft-versus-host-disease

Start date: 2026-06-01
Primary completion: 2033-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.